Centre for Health Services Research, Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
Institute of Health and Biomedical Innovation, School of Public Health and Social Work, Queensland University of Technology, Brisbane, Queensland, Australia.
Dermatology. 2020;236(2):90-96. doi: 10.1159/000506154. Epub 2020 Feb 28.
Previous cross-sectional research indicates high acceptance of mobile teledermoscopy-enhanced skin self-examination (SSE) by consumers based on the technology acceptance model (TAM) domains: perceived usefulness, ease of use, compatibility, attitude and intention, subjective norms, facilitator, and trust. However, no study has assessed this outcome longitudinally among people who actually used the technology in their own homes.
Participants were living in Brisbane, Australia, aged 18 years or older, and at high risk of skin cancer. Participants randomly assigned to the intervention group (n = 98) completed a self-administered questionnaire on mobile teledermoscopy acceptance for skin cancer detection both before use and after performing mobile teledermoscopy-enhanced SSE in their homes. The survey included a 25-item scale assessing seven TAM domains. Item scores ranged from 5 (strongly agree) to 1 (strongly disagree). Participants also answered survey questions on satisfaction with use of teledermoscopy, and a 9-item "thoughts about melanoma" scale that measures cancer worry.
Participants were 19-73 years old, had high skin cancer risk, blue or grey eyes (53.1%), fair or very fair skin (88.8%), and previous skin cancer treatments (61.2%). Participants were more accepting of mobile teledermoscopy at baseline: mean TAM score of 4.15 (SE 0.05); their level of acceptance decreased significantly after teledermoscopy use: mean score 3.94 (SE 0.05; p = 0.001). In linear regression analysis, the decrease in TAM scores was similar across demographic and skin cancer risk categories. Ninety-two percent (n = 90) of participants agreed that mobile teledermoscopy was easy to use. The mean score of the "thoughts about melanoma" scale did not change significantly from baseline to follow-up.
Consumers had high TAM scores before they used mobile teledermoscopy within a randomised control trial. At the end of the intervention period, TAM scores decreased, although participants' average score still indicated "agreement" that mobile teledermoscopy was acceptable.
基于技术接受模型(TAM)的感知有用性、易用性、兼容性、态度和意向、主观规范、促进因素和信任等领域,先前的横断面研究表明,消费者对移动远程皮肤镜增强自我检查(SSE)的接受程度很高。然而,尚无研究在实际在家中使用该技术的人群中对该结果进行纵向评估。
参与者居住在澳大利亚布里斯班,年龄在 18 岁或以上,且患皮肤癌风险较高。随机分配到干预组的参与者(n=98)在使用移动远程皮肤镜在家中进行增强 SSE 前后,均完成了一份关于移动远程皮肤镜检测皮肤癌接受度的自我管理问卷。该调查包括评估七个 TAM 领域的 25 项量表。各项目评分范围为 5(非常同意)至 1(非常不同意)。参与者还回答了关于使用远程皮肤镜满意度的调查问题,以及一个衡量癌症担忧的 9 项“黑色素瘤想法”量表。
参与者年龄在 19-73 岁之间,皮肤癌风险高,蓝或灰色眼睛(53.1%),浅色或非常浅色皮肤(88.8%),并接受过皮肤癌治疗(61.2%)。参与者在基线时对移动远程皮肤镜的接受度更高:TAM 平均得分为 4.15(SE 0.05);在使用远程皮肤镜后,他们的接受度显著下降:平均得分为 3.94(SE 0.05;p=0.001)。线性回归分析表明,TAM 评分的下降在人口统计学和皮肤癌风险类别中相似。92%(n=90)的参与者认为移动远程皮肤镜易于使用。“黑色素瘤想法”量表的平均分数从基线到随访没有显著变化。
消费者在随机对照试验中在家中使用移动远程皮肤镜之前,TAM 评分较高。在干预期结束时,TAM 评分下降,尽管参与者的平均评分仍表示“同意”移动远程皮肤镜是可以接受的。